Phoenix, Arizona 85016


Purpose:

The Early Head Start program serves lower socioeconomic inner-city children from birth to 3 years. This population has a higher incidence of asthma due to increased exposures. The primary objective of this study is: To evaluate the effect of early identification of these high risk, inner-city asthmatic infants, age 1-3 years, and early treatment with pulmicort respules on asthma morbidity (asthma symptoms and use of rescue medications), infant pulmonary functions, and use of health care resources (unscheduled clinic visits, emergency room visits and hospitalizations). To obtain pilot behavior information using Carey Temperament Scale, Bitsea and expand to Itsea if indicated.


Criteria:

Inclusion Criteria: - Children 12-36 months of age with a history of wheezing or airway reactivity responding to bronchodilators, or diagnosed with asthma by a physician. Exclusion Criteria: - Children less than 12 months or greater than 36 months of age. - Children diagnosed with attention deficit disorder by a physician or psychologist.


NCT ID:

NCT00624429


Primary Contact:

Principal Investigator
Peggy Radford, MD
Phoenix Children's Hospital

Peggy Radford, MD
Phone: 602-546-0985
Email: pradfor@phoenixchildrens.com


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85016
United States

Peggy Radford, MD
Phone: 602-546-0985
Email: pradfor@phoenixchildrens.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.